Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma - Quaterly Results
Date: 10-11-2022
The Revenue for the quarter ended September 2022 of Rs. 3511.00 millions grew by 6.27 % from Rs. 3304.00 millions.A slender decline of -29.66% was recorded to Rs. 377.00 millions from Rs. 536.00 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 863.00 millions from 897.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 3511.00 | 3304.00 | 6.27 | 11568.00 | 7242.00 | 59.73 | 17678.00 | 16535.00 | 6.91 |
| Other Income | 162.00 | 403.00 | -59.80 | 494.00 | 526.00 | -6.08 | 946.00 | 1011.00 | -6.43 |
| PBIDT | 863.00 | 897.00 | -3.79 | 4989.00 | 2156.00 | 131.40 | 3076.00 | 5187.00 | -40.70 |
| Interest | 17.00 | 32.00 | -46.88 | 44.00 | 50.00 | -12.00 | 133.00 | 113.00 | 17.70 |
| PBDT | 846.00 | 865.00 | -2.20 | 4945.00 | 2106.00 | 134.81 | 2943.00 | 5074.00 | -42.00 |
| Depreciation | 383.00 | 342.00 | 11.99 | 752.00 | 673.00 | 11.74 | 1384.00 | 1152.00 | 20.14 |
| PBT | 463.00 | 523.00 | -11.47 | 4193.00 | 1433.00 | 192.60 | 1559.00 | 3922.00 | -60.25 |
| TAX | 86.00 | -13.00 | -761.54 | 736.00 | 145.00 | 407.59 | 168.00 | 827.00 | -79.69 |
| Deferred Tax | -6.00 | -113.00 | -94.69 | -16.00 | -110.00 | -85.45 | -157.00 | -106.00 | 48.11 |
| PAT | 377.00 | 536.00 | -29.66 | 3457.00 | 1288.00 | 168.40 | 1391.00 | 3095.00 | -55.06 |
| Equity | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 |
| PBIDTM(%) | 24.58 | 27.15 | -9.46 | 43.13 | 29.77 | 44.87 | 17.40 | 31.37 | -44.53 |